Literature DB >> 31017248

Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials.

Gil Yosipovitch1, Jennifer Soung, Jonathan Weiss, Elisa Muscianisi, Xiangyi Meng, Isabelle Gilloteau, Boni E Elewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31017248     DOI： 10.2340/00015555-3195

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

Review 1.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

Review 2.  Molecular and Cellular Mechanisms of Itch in Psoriasis.

Authors:  Eriko Komiya; Mitsutoshi Tominaga; Yayoi Kamata; Yasushi Suga; Kenji Takamori
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

Review 3.  Emerging Therapeutic Options for Chronic Pruritus.

Authors:  Radomir Reszke; Piotr Krajewski; Jacek C Szepietowski
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 4.  A New Generation of Treatments for Itch.

Authors:  Emilie Fowler; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

5.  Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.

Authors:  Fei Li; Dan Han; Bo Wang; Wentao Zhang; Yan Zhao; Jing Xu; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Journal:  Mediators Inflamm       Date:  2022-01-11       Impact factor: 4.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.